IRIDEX Announces Third Quarter 2013 Conference Call and Release Date

     IRIDEX Announces Third Quarter 2013 Conference Call and Release Date

PR Newswire

MOUNTAIN VIEW, Calif., Oct. 24, 2013

MOUNTAIN VIEW, Calif., Oct. 24, 2013 /PRNewswire/ --IRIDEX Corporation
(NASDAQ: IRIX) today announced that it will release its third quarter 2013
financial results after the market closes on Thursday, October 31, 2013. In
conjunction with the release, the Company will host a conference call with the
investment community at 5:00 p.m. Eastern Time on Thursday, October 31, 2013
to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by
dialing (888) 549-7880 U.S. or (480) 629-9644 (International) and quoting
Conference ID 4646160, or by visiting the Company's website at
www.iridex.com. A telephone replay will be available beginning on Thursday,
October 31, 2013 through Thursday, November 7, 2013 by dialing (800) 406-7325
(US) or (303) 590-3030 (International) and entering Access Code 4646160.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in
developing, manufacturing, and marketing innovative and versatile laser-based
medical systems, delivery devices and consumable instrumentation for the
ophthalmology market. We maintain a deep commitment to the success of our
customers, with comprehensive technical, clinical, and service support
programs. IRIDEX is dedicated to a standard of excellence, offering superior
technology for superior results. IRIDEX products are sold in the United States
through both direct and independent sales forces and internationally through a
combination of a direct sales force and a network of approximately 70
independent distributors into over 100 countries. For further information,
visit the Company's website at http://www.iridex.com.

SOURCE IRIDEX

Website: http://www.iridex.com
Contact: Company Contact: Jim Mackaness, CFO & COO, 650-940-4700, or Investor
Relations Contact: Matt Clawson, Allen & Caron, 949-474-4300,
matt@allencaron.com